Clinical Trial

Effect of HBOT on Femoral Head Avascular Necrosis (AVN)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to determine whether the Hyperbaric Oxygen Therapy (HBOT) conducted under the Marx Protocol improves pain outcomes when combined with core decompression with autologous bone marrow aspirate concentrate to treat patients with femoral head avascular necrosis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-08; most recent amendment 2026-06-30.
Trial Details
NCT Number NCT06931301
Lead Sponsor Yale University
Conditions Osteonecrosis, Avascular Necrosis
Enrollment 400 participants
Start Date 2026-12
Primary Completion 2035-04 (estimated)
Study Completion 2035-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-01